| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
AMEX: SFCC |
| Security Type |
Common Stock |
| Lead Underwriter |
H. D. Brous |
| Days In Registration |
421 |
| Date Filed |
17-Aug-1999 |
| Form Filed | S-B2 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Pers/Bus/Rep Svc |
| Business Description |
Provide clinical research and drug development services for clients in the Pharmaceutical and biotechnology industries |
| Revenue |
$19.7M |
| Net Income |
$2.1M |
| Shares Outstanding (post-offering) |
2.34M |
| Contact |
Mr. Arnold Hantman |
| Number of Employees |
187 |
|
| Original Filing Information |
| US |
| Shares Filed |
1.15M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
1.15M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
168.75K |
| File Amount |
$6.9M |
| File Price Range |
$6.50 - $5.50 |
| File Mid Price |
$6.00 |
Current Filing Information
(Amended 6-Oct-2000) |
|
US |
|
Shares Filed |
1.25M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
1.25M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$10.0M |
| · % Change from Original |
44.93 |
| File Price Range |
$8.00 - $8.00 |
| File Mid Price |
$8.00 |
|
